| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |